Market Cap 2.40B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 8,429,022
Avg Vol 8,594,492
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 73%
Beta 1.18
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Jul. 2 at 9:20 PM
$ABCL Weekly close over $8
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jul. 2 at 8:56 PM
$ABCL you would be crazy to sell before IPO price
2 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 2 at 8:10 PM
$ABCL $ABCL to $25+ EOY. That is all
1 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High Jul. 2 at 8:02 PM
$ABCL Great price action heading into the weekend.
0 · Reply
Cryptocr7
Cryptocr7 Jul. 2 at 8:00 PM
$ABCL nice close
1 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 2 at 6:05 PM
$ABCL The strength of $ABCL in a red market with minimal volume is giving me hope that something big is about to happen 👀😉
1 · Reply
tranq19
tranq19 Jul. 2 at 5:56 PM
$ABCL august maybe, or with earnings first week or so of August? Some sites showing not recruiting
3 · Reply
The_Blunderer
The_Blunderer Jul. 2 at 4:43 PM
$ABCL I just bought some shares. Looks like a winner in the (near) future
0 · Reply
PaloPB
PaloPB Jul. 2 at 3:35 PM
$ABCL ,📈✅
1 · Reply
Ckkung71
Ckkung71 Jul. 2 at 3:22 PM
$ABCL Best thing to do right now is just sit on your shares don’t let them fool you with all trapps..
1 · Reply
Latest News on ABCL
AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 27 days ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 7 weeks ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 2 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 3 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 4 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 4 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 6 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 8 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 8 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 10 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 10 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 11 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Stocktradesmoon
Stocktradesmoon Jul. 2 at 9:20 PM
$ABCL Weekly close over $8
0 · Reply
PLTRLONGDONG
PLTRLONGDONG Jul. 2 at 8:56 PM
$ABCL you would be crazy to sell before IPO price
2 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 2 at 8:10 PM
$ABCL $ABCL to $25+ EOY. That is all
1 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High Jul. 2 at 8:02 PM
$ABCL Great price action heading into the weekend.
0 · Reply
Cryptocr7
Cryptocr7 Jul. 2 at 8:00 PM
$ABCL nice close
1 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 2 at 6:05 PM
$ABCL The strength of $ABCL in a red market with minimal volume is giving me hope that something big is about to happen 👀😉
1 · Reply
tranq19
tranq19 Jul. 2 at 5:56 PM
$ABCL august maybe, or with earnings first week or so of August? Some sites showing not recruiting
3 · Reply
The_Blunderer
The_Blunderer Jul. 2 at 4:43 PM
$ABCL I just bought some shares. Looks like a winner in the (near) future
0 · Reply
PaloPB
PaloPB Jul. 2 at 3:35 PM
$ABCL ,📈✅
1 · Reply
Ckkung71
Ckkung71 Jul. 2 at 3:22 PM
$ABCL Best thing to do right now is just sit on your shares don’t let them fool you with all trapps..
1 · Reply
DeMampCamp
DeMampCamp Jul. 2 at 2:22 PM
$ABCL You can't hide $10, we see you in our sights :)
0 · Reply
Odoji
Odoji Jul. 2 at 2:19 PM
$ABCL 💉
0 · Reply
Kylenorth
Kylenorth Jul. 2 at 2:18 PM
$ABCL BO coming!! thanks for leaving Niel
0 · Reply
Arnoldsens
Arnoldsens Jul. 2 at 2:17 PM
$ABCL This will be above 10 by the middle of next week if all goes well in the world.
0 · Reply
KryptonResearch
KryptonResearch Jul. 2 at 2:14 PM
AI-enabled healthcare/research is the most obvious massive winner… $ABCL $SLS $RXRX $IBRX $TEM etc… We take a look at a lesser known name in this space, with similar, if not greater upside potential given their ownership of the data layer. This is the next big sector, we have our pick, but there are so many names that will pay well. https://kryptonresearch.substack.com/p/blood-money
1 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 2 at 2:12 PM
$ABCL Dip N Rip just like I said.
0 · Reply
QuietTrader
QuietTrader Jul. 2 at 2:01 PM
Stocks to watch: $OKLO $ONDS $ABCL $KLAC (piling into this one this morning - traded a few in and out - currently 1000 shares at 262.08 average). This is in the perfect entry spot.
0 · Reply
Cassek86
Cassek86 Jul. 2 at 2:00 PM
$ABCL I hope the shorts enjoyed the Bear trap yesterday.
0 · Reply
jacckkmm
jacckkmm Jul. 2 at 1:58 PM
$ABCL AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the Top 10 Hot Stocks with the Highest Upside Potential. On June 5, AbCellera Biologics Inc. (NASDAQ:ABCL) reported that it has appointed Dr. Victor Sandor, M.D.C.M, to its Board of Directors as an independent director. Dr. Sandor is a medical oncologist with extensive experience in developing companies and helping bring new medicines to patients. He previously served as Chief Medical Officer at Array BioPharma, where he played a key role in securing approval for Braftovi (encorafenib) and Mektovi (binimetinib).
0 · Reply
jacckkmm
jacckkmm Jul. 2 at 1:57 PM
$ABCL Is AbCellera Biologics (ABCL) One of the Best Stocks with Biggest Upside? Ali Ahmed Wed, July 1, 2026 at 5:23 PM EDT 2 min read
0 · Reply
tradersunion353
tradersunion353 Jul. 2 at 12:35 PM
$ABCL shameless maggott paper traders will be all over with adding loading, this is a gift comments annoying paper traders
3 · Reply
jacckkmm
jacckkmm Jul. 2 at 11:46 AM
$ABCL The research firm said that it is now looking ahead to Phase 2 data expected in the third quarter of 2026. It expects the data to match or exceed the effectiveness seen with Veozah and Lynkuet. Truist believes AbCellera Biologics Inc. (NASDAQ:ABCL) offers an attractive risk-reward opportunity before those results are released.
0 · Reply